Surgical techniques for improving outcomes in pancreatic ductal adenocarcinoma

被引:5
|
作者
Gall, Tamara M. H. [1 ]
Thompson, Zoe [1 ]
Dinneen, Eoin P. [1 ]
Sodergren, Mikael [1 ]
Pai, Madhava [1 ]
Frampton, Adam E. [1 ]
Jiao, Long R. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, HPB Surg Unit, Dept Surg & Canc, London W12 0HS, England
关键词
irreversible electroporation therapy; laparoscopic surgery; no-touch technique; pancreatic cancer; pancreaticoduodenectomy; radiofrequency ablation; robotic surgery; venous and arterial resection; MICROSCOPICALLY NEGATIVE MARGINS; TOUCH ISOLATION TECHNIQUE; SUPERIOR MESENTERIC VEIN; VASCULAR RESECTION; R1; RESECTION; IRREVERSIBLE ELECTROPORATION; OPEN PANCREATICODUODENECTOMY; PORTOVENOUS STRUCTURES; MICROWAVE ABLATION; HEAD CANCER;
D O I
10.1586/17474124.2014.881251
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic ductal adenocarcinoma is a devastating disease with extremely poor survival despite patients undergoing potentially curative resections and improvements in chemotherapeutic agents. Surgery for operable cancer in the head of the pancreas typically involves an open pancreaticoduodenectomy with a post-operative median survival of 21 months. Newer surgical techniques, however, aim to improve patient outcomes in terms of both their hospital experience and better oncological results. This article focuses on the evidence to date for some of these surgical techniques including laparoscopic and robotic surgery, the no-touch technique, venous and arterial resection, intra-operative radiofrequency ablation and intra-operative irreversible electroporation. With the increased use of these techniques we hope to see better quality of life and survival for these patients.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 50 条
  • [41] Surgery for pancreatic ductal adenocarcinoma
    Vera, R.
    Diez, L.
    Martin Perez, E.
    Plaza, J. C.
    Sanjuanbenito, A.
    Carrato, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (11): : 1303 - 1311
  • [42] Models of pancreatic ductal adenocarcinoma
    Dennaoui, Rayane
    Shrestha, Hridaya
    Wagner, Kay-Uwe
    CANCER AND METASTASIS REVIEWS, 2021, 40 (03) : 803 - 818
  • [43] MicroRNAs in pancreatic ductal adenocarcinoma
    Park, Jong Y.
    Helm, James
    Coppola, Domenico
    Kim, Donghwa
    Malafa, Mokenge
    Kim, Seung Joon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (07) : 817 - 827
  • [44] Hypoxia and pancreatic ductal adenocarcinoma
    Yamasaki, Akio
    Yanai, Kosuke
    Onishi, Hideya
    CANCER LETTERS, 2020, 484 : 9 - 15
  • [45] Macrophages and pancreatic ductal adenocarcinoma
    Habtezion, Aida
    Edderkaoui, Mouad
    Pandol, Stephen J.
    CANCER LETTERS, 2016, 381 (01) : 211 - 216
  • [46] Staging of pancreatic ductal adenocarcinoma
    Sauvanet, A
    Zins, M
    JOURNAL DE CHIRURGIE, 1998, 135 (01): : 10 - 16
  • [47] FOLFIRINOX for Pancreatic Ductal Adenocarcinoma
    Alakus, Hakan
    Korenkov, Michael
    Kuetting, Fabian
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (08): : 726 - 727
  • [48] Immunotherapy for pancreatic ductal adenocarcinoma
    Carpenter, Eileen
    Nelson, Sarah
    Bednar, Filip
    Cho, Clifford
    Nathan, Hari
    Sahai, Vaibhav
    di Magliano, Marina Pasca
    Frankel, Timothy L.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 751 - 759
  • [49] Biomarkers in pancreatic ductal adenocarcinoma
    Gallego, J.
    Lopez, C.
    Pazo-Cid, R.
    Lopez-Rios, F.
    Carrato, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12): : 1430 - 1437
  • [50] Desmoplasia of Pancreatic Ductal Adenocarcinoma
    Pandol, Stephen
    Edderkaoui, Mouad
    Gukovsky, Ilya
    Lugea, Aurelia
    Gukovskaya, Anna
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (11) : S44 - S47